One of the other reforms that we made is that when a drug is rejected, there is the opportunity for reasonably rapid resubmission. As I have said earlier and in public, I encourage the manufacturers of these particular drugs to reconsider the price and, at the earliest opportunity, offer the taxpayer and those who are suffering a better deal so that, hopefu...